| 
	| manager |  |  
	| language | - |  
| license | - |  
| created at | 2021-05-11 01:03:40 UTC |  
| updated at | 2021-05-11 05:08:34 UTC |  | 
Just test
 | 596 entries | 
There is 0 pattern entry.
  
      
    
    
    
  
    
  | mechanical ventilation | Therapy |  | 
  | methylprednisolone and low molecular weight heparin | Therapy |  | 
  | methylprednisolone and unfractionated heparin | Therapy |  | 
  | movement restriction | Therapy |  | 
  | non-invasive mechanical ventilation | Therapy |  | 
  | not receive any treatment | Therapy |  | 
  | Prevention of or induction of TxA2 | Therapy |  | 
  | Recombinant ACE2 | Therapy |  | 
  | sarilumab + methylprednisolone plus SOC for COVID-19 | Therapy |  | 
  | sarilumab plus SOC | Therapy |  | 
  | social distancing | Therapy |  | 
  | surgical intervention | Therapy |  | 
  | target RAS using specific candidate chemotherapeutic drugs | Therapy |  | 
  | transfusion of 2 or more units of packed red blood cells in a day | Therapy |  | 
  | with corticosteroids | Therapy |  |